Last reviewed · How we verify
NCT03512665
Evaluation of the Impact of a Nutritional Supplement Made of Vegetable Oils in People at Risk of Diabetes
NA trial testing Full dose supplement in Insulin Resistance in 25 participants. Completed in 2 October 2018.
16 June 2018
Quick facts
| Lead sponsor | University of Los Andes, Columbia |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 25 |
| Start date | 7 April 2018 |
| Primary completion | 16 June 2018 |
| Estimated completion | 2 October 2018 |
| Sites | 1 location across Colombia |
Drugs / interventions tested
- Full dose supplement
- Low dose Supplement
- Control Oil
Conditions studied
- Insulin Resistance — all drugs for Insulin Resistance →
Sponsor
University of Los Andes, Columbia
Who can join
18 and older, any sex, with Insulin Resistance. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Metabolic and cardiovascular diseases are the first cause of morbidity and mortality throughout the world, including Latin America and Colombia. Asymptomatic elevations of blood glucose, insufficient response to normal insulin concentrations (called insulin resistance), overweight and obesity can cause severe damage to body organs, leading to complications and even death. Worryingly, the prevalence of prediabetes is on the rise and efforts in public health policies made to contain this epidemic have had a very limited impact. This has prompted an intense search for non-pharmacological interventions. One of the most promising areas is research on "nutraceuticals", foods capable of positively impacting risk factors. However, there are insufficient nutritional or supplementary alternatives to favorably impact carbohydrate metabolism and cardiovascular risk factors in individuals at risk of diabetes. This project will evaluate the effects of the administration of a dietary supplement composed of vegetable oils. The fat composition of these oils is likely to impact positively on the metabolic profile of subjects at risk of diabetes and cardiovascular conditions.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Impact of a Formulation Containing Unusual Polyunsaturated Fatty Acids, Trace Elements, Polyphenols and Plant Sterols on Insulin Resistance and Associated Disturbances.
Peláez-Jaramillo MJ, Valencia-Enciso N, Cárdenas-Mojica AA, Gaete PV, et al · · 2020 · cited 3× · PMID 31691133 · DOI 10.1007/s13300-019-00721-z
Verify or expand the search:
- PubMed search for NCT03512665
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Insulin Resistance
Currently open trials in the same condition.
- NCT07403604 — Effect of Insulin Lowering on Lipogenesis · Phase 1 · recruiting
- NCT07226128 — The Effects of Cognitive Behavioral Therapy on Insulin Resistance in People With HIV · NA · recruiting
- NCT07505745 — MOTS-c for Improving Insulin Sensitivity in Adults With Prediabetes and Overweight/Obesity · Phase 2 · recruiting
- NCT07220694 — Effects of Sabroxy® Supplementation on Insulin Resistance and Cognitive Function in Adults With Mild Cognitive Impairmen · NA · recruiting
- NCT06768827 — New Mechanisms of Obesity · NA · recruiting
Other University of Los Andes, Columbia trials
Trials by the same sponsor.
- NCT07148531 — Caregiver Mental Health and Early Childhood Development in Conflict-Affected Settings · NA · active not recruiting
- NCT06579456 — Evaluation in a Multimodal Structured Curriculum of Laparoscopic Surgery · NA · completed
- NCT04647305 — Effectiveness and Adherence to Closed Face Shields to Prevent COVID-19 Transmission · NA · completed
- NCT04647318 — Physiological Response to Self-compassion Versus Relaxation · NA · completed
- NCT03502252 — Experimental Evaluation of Semillas de Apego · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03512665 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Los Andes, Columbia
- Last refreshed: 11 October 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03512665.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing